RVL Pharmaceuticals, Inc.

400 Crossing Boulevard, Bridgewater,  NJ 
United States
  • Booth: 34

We are RVL Pharmaceuticals, Inc., the ophthalmic subsidiary of Osmotica Pharmaceuticals PLC (NASDAQ: OSMT).  We couldn’t be more excited to introduce ourselves to you.  We might be new to the game but we are poised to change it.  We’re motivated to do things differently, and the recent FDA approval of UPNEEQ™ (oxymetazoline hydrochloride ophthalmic solution), 0.1% provides the foundation for us to realize a transformational vision in eye care.  We are passionate people behind a purposeful business strategy. Our mission? Deliver unique customer experiences through truly innovative solutions. We’re inspired to be BOLD, and invite you to join our ReVoLution.  Please see below to learn more about UPNEEQ™. 


For technical assistance with this webpage please click here.